German Switch: Azelastine-Fluticasone Nasal Spray Approved On Second Try, Cytisine Rejected Again

Germany's Expert Committee on Prescription recommends the Rx-to-OTC switch of an azelastine and fluticasone propionate combination nasal spray, the second time around. Low-cost smoking cessation drug cytisine, on the other hand, is denied - also the second time it has appeared before the committee.  

Rendering of a German flag

At its most recent meeting, Germany’s Expert Committee on Prescription, the SVA, has recommended the Rx-to-OTC switch of an azelastine and fluticasone propionate combination nasal spray.

The second attempt by an undisclosed applicant – likely Viatris, which markets a prescription azelastine and fluticasone propionate combination nasal...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Europe

More from Geography